---
title: "CKM Burden Predicts Echocardiographic Recovery and Cardiovascular Events in Hypertension"
id: "medrxiv-6-impact-of-cardiovascular-kidney-metabolic-burden-on-echocardiographic"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-6-impact-of-cardiovascular-kidney-metabolic-burden-on-echocardiographic"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.21.26366110v1?rss=1"
published_at: "2026-10-23T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# CKM Burden Predicts Echocardiographic Recovery and Cardiovascular Events in Hypertension
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-6-impact-of-cardiovascular-kidney-metabolic-burden-on-echocardiographic
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.21.26366110v1?rss=1)
- **Published At:** 2026-10-23T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The registry cohort included 1,600 patients from STRATS-HHD who underwent baseline and 6–18 month follow-up echocardiography. - Investigators defined cardiovascular-kidney-metabolic (CKM) burden by four components: obesity, diabetes, chronic kidney disease, and severe hypertension; patients were grouped as 0–1, 2, or ≥3 components. - CKM burden distribution: 973 (60.8%) with 0–1, 440 (27.5%) with 2, and 187 (11.7%) with ≥3 components. - The primary outcome was a composite of cardiovascular death or heart failure hospitalization (HHF). - Higher CKM burden associated with greater baseline cardiac abnormalities; the cohort with ≥3 components had the worst baseline echocardiographic profiles, investigators reported. - Adjusted risk for the primary outcome increased with CKM burden: adjusted HR 3.09 (95% CI, 1.92–4.98) for ≥3 versus 0–1; risk rose by adjusted HR 1.53 (95% CI, 1.27–1.84) per additional CKM component. - The association persisted after further adjustment for metabolic dysfunction-associated steatotic liver disease, defined by hepatic steatosis index, the authors noted. - After treatment most echocardiographic parameters improved overall, but patients with CKM ≥3 showed less favorable E/e′, **LV global longitudinal strain (GLS)**, and LA stiffness index at follow-up. - Normalization of these specific echocardiographic measures at follow-up correlated with substantially lower subsequent cardiovascular risk. - Mediation analysis indicated that persistent echocardiographic abnormalities partially mediated the link between high CKM burden and the primary outcome. - The study was retrospective, registry-based; ethical approvals and waiver of informed consent were documented. Data are available from the corresponding author on request.
## Clinical Analysis & Structured Key Points
Impact of Cardiovascular-Kidney-Metabolic Burden on Echocardiographic Remodeling and Cardiovascular Outcomes in Hypertension | medRxiv Skip to main content Impact of Cardiovascular-Kidney-Metabolic Burden on Echocardiographic Remodeling and Cardiovascular Outcomes in Hypertension Hyue Mee Kim , Minjung Bak , Jiesuck Park , Hong-Mi Choi , Yeonyee E. Yoon , Goo-Yeong Cho , View ORCID Profile In-Chang Hwang doi: https://doi.org/10.64898/2026.10.21.26366110 Hyue Mee Kim 1 Chung Ang University Hospital; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Minjung Bak 2 Seoul National University Bundang Hospital Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jiesuck Park 2 Seoul National University Bundang Hospital Find this author on Google Scholar Find this author on PubMed Search for this author on this site Hong-Mi Choi 2 Seoul National University Bundang Hospital Find this author on Google Scholar Find this author on PubMed Search for this author on this site Yeonyee E. Yoon 2 Seoul National University Bundang Hospital Find this author on Google Scholar Find this author on PubMed Search for this author on this site Goo-Yeong Cho 2 Seoul National University Bundang Hospital Find this author on Google Scholar Find this author on PubMed Search for this author on this site In-Chang Hwang 2 Seoul National University Bundang Hospital Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for In-Chang Hwang For correspondence: inchang.hwang{at}gmail.com Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Aims: Cardiovascular-kidney-metabolic (CKM) syndrome highlights the interrelationship between metabolic, renal, and cardiovascular disorders. However, whether CKM burden influences longitudinal cardiac structural and functional recovery and subsequent cardiovascular outcomes remains unclear. Methods: We studied 1,600 patients from the STRATS-HHD registry who underwent echocardiography at baseline and 6-18 months after treatment initiation. CKM burden was defined by obesity, diabetes, chronic kidney disease, and severe hypertension (0-1, 2, or ≥3 components). The primary outcome was cardiovascular death or heart failure hospitalization (HHF). Results: CKM burden was 0-1 in 973 patients (60.8%), 2 in 440 (27.5%), and ≥3 in 187 (11.7%). Higher burden was associated with worse baseline cardiac abnormalities and increased primary outcome risk (adjusted HR, 3.09; 95% CI, 1.92-4.98 for ≥3 vs 0-1; adjusted HR, 1.53; 95% CI, 1.27-1.84 per +1 CKM component). The prognostic association persisted after additional adjustment for hepatic steatosis index-defined metabolic dysfunction-associated steatotic liver disease. Despite overall improvement in most echocardiographic parameters after treatment, patients with CKM burden ≥3 showed less favorable E/e′, LV global longitudinal strain (GLS), and LA stiffness index at follow-up. Normalization of these parameters at follow-up was associated with substantially lower subsequent cardiovascular risk. Mediation analyses suggested that echocardiographic abnormalities partially mediated the association between high CKM burden and the primary outcome. Conclusion: CKM burden identifies hypertensive patients with less favorable cardiac function after treatment and increased cardiovascular risk. These findings highlight the association of CKM burden with cardiac functional recovery and prognosis in patients with hypertension. Competing Interest Statement Y.E.Y. is currently affiliated with Ontact Health Co., Ltd., the company that developed the deep learning-based automated strain measurement platform used in this study, and holds equity in Ontact Health Co., Ltd. The other authors have no conflicts of interest to declare. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Institutional Review Board of the Clinical Research Institute at Seoul National University Bundang Hospital (No. B-2206-762-102) and the Institutional Review Board at Chung-Ang University Hospital (No. 2205-014-19419) gave ethical approval for this work, and waived the requirement for informed consent, given the retrospective nature of the study and minimal expected risk to the participants. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability The datasets used and analyzed during the current study are available from the corresponding author on reasonable request. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted October 23, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Impact of Cardiovascular-Kidney-Metabolic Burden on Echocardiographic Remodeling and Cardiovascular Outcomes in Hypertension Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Impact of Cardiovascular-Kidney-Metabolic Burden on Echocardiographic Remodeling and Cardiovascular Outcomes in Hypertension Hyue Mee Kim , Minjung Bak , Jiesuck Park , Hong-Mi Choi , Yeonyee E. Yoon , Goo-Yeong Cho , In-Chang Hwang medRxiv 2026.10.21.26366110; doi: https://doi.org/10.64898/2026.10.21.26366110 Share This Article: Copy Citation Tools Impact of Cardiovascular-Kidney-Metabolic Burden on Echocardiographic Remodeling and Cardiovascular Outcomes in Hypertension Hyue Mee Kim , Minjung Bak , Jiesuck Park , Hong-Mi Choi , Yeonyee E. Yoon , Goo-Yeong Cho , In-Chang Hwang medRxiv 2026.10.21.26366110; doi: https://doi.org/10.64898/2026.10.21.26366110 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (634) Allergy and Immunology (914) Anesthesia (346) Cardiovascular Medicine (4943) Dentistry and Oral Medicine (490) Dermatology (425) Emergency Medicine (672) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1667) Epidemiology (16164) Forensic Medicine (35) Gastroenterology (1236) Genetic and Genomic Medicine (7213) Geriatric Medicine (747) Health Economics (1091) Health Informatics (5222) Health Policy (1456) Health Systems and Quality Improvement (1812) Hematology (597) HIV/AIDS (1370) Infectious Diseases (except HIV/AIDS) (16427) Intensive Care and Critical Care Medicine (1192) Medical Education (690) Medical Ethics (156) Nephrology (739) Neurology (7499) Nursing (375) Nutrition (1114) Obstetrics and Gynecology (1281) Occupational and Environmental Health (1031) Oncology (3708) Ophthalmology (1079) Orthopedics (401) Otolaryngology (462) Pain Medicine (493) Palliative Medicine (142) Pathology (717) Pediatrics (1844) Pharmacology and Therapeutics (749) Primary Care Research (781) Psychiatry and Clinical Psychology (6065) Public and Global Health (9915) Radiology and Imaging (2499) Rehabilitation Medicine and Physical Therapy (1500) Respiratory Medicine (1263) Rheumatology (655) Sexual and Reproductive Health (794) Sports Medicine (594) Surgery (795) Toxicology (109) Transplantation (315) Urology (303)
## Related Clinical Research

- [Comparing BMI, Waist Circumference, and BRI for Predicting ASCVD, AF, and Mortality in 1.2M Koreans](https://medichelpline.com/clinical-feed/plos-one-14-prognostic-associations-of-anthropometric-indices-with-major-health-outcomes-a.md)
- [Potassium-rich DASH diet appears safe for adults on common blood pressure meds](https://medichelpline.com/clinical-feed/aha-news-0-potassium-rich-dash-diet-found-safe-for-adults-taking-common-blood-pressure.md)
- [GLP-1 Receptor Agonists and Pulmonary Hypertension: Mechanistic Rationale and Evidence Gaps](https://medichelpline.com/clinical-feed/pubmed-42747605.md) (DOI: 10.1007/s00408-026-00939-2)
- [Lifestyle Changes May Help Prevent Multimorbidity In Prediabetes](https://medichelpline.com/clinical-feed/medical-news-today-23-diet-weight-loss-and-150-minutes-of-exercise-may-protect-against-chronic.md)
- [Moving Forward: The Future of GLP-1 Therapies](https://medichelpline.com/clinical-feed/endocrine-news-18-moving-forward-the-future-of-glp-1-therapies.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.